AU2003227472A1 - Downsized core tablet containing nifedipine - Google Patents

Downsized core tablet containing nifedipine

Info

Publication number
AU2003227472A1
AU2003227472A1 AU2003227472A AU2003227472A AU2003227472A1 AU 2003227472 A1 AU2003227472 A1 AU 2003227472A1 AU 2003227472 A AU2003227472 A AU 2003227472A AU 2003227472 A AU2003227472 A AU 2003227472A AU 2003227472 A1 AU2003227472 A1 AU 2003227472A1
Authority
AU
Australia
Prior art keywords
downsized
tablet containing
core tablet
containing nifedipine
nifedipine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003227472A
Inventor
Makoto Matsuoka
Takaaki Nishioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2003227472A1 publication Critical patent/AU2003227472A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AU2003227472A 2002-03-27 2003-03-26 Downsized core tablet containing nifedipine Abandoned AU2003227472A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-88218 2002-03-27
JP2002088218 2002-03-27
PCT/JP2003/003683 WO2003080057A1 (en) 2002-03-27 2003-03-26 Downsized core tablet containing nifedipine

Publications (1)

Publication Number Publication Date
AU2003227472A1 true AU2003227472A1 (en) 2003-10-08

Family

ID=28449431

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003227472A Abandoned AU2003227472A1 (en) 2002-03-27 2003-03-26 Downsized core tablet containing nifedipine

Country Status (2)

Country Link
AU (1) AU2003227472A1 (en)
WO (1) WO2003080057A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8153160B2 (en) 2005-07-06 2012-04-10 Bayer Pharma Aktiengesellschaft Pharmaceutical dosage forms comprising an active ingredient combination of nifedipine and/or nisoldipine and an angiotensin II antagonist
US9993432B2 (en) 2008-11-27 2018-06-12 Bayer Intellectual Property Gmbh Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin II antagonist and/or a diuretic

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007001067A2 (en) * 2005-06-27 2007-01-04 Daiichi Sankyo Company, Limited Solid dosage form comprising an angiotensin ii receptor antagonist and a calcium channel blocker
ES2612532T3 (en) 2012-05-07 2017-05-17 Bayer Pharma Aktiengesellschaft Method of manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720757A1 (en) * 1987-06-24 1989-01-05 Bayer Ag DHP COAT TABLET
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
WO1993005770A1 (en) * 1991-09-20 1993-04-01 Fujisawa Pharmaceutical Co., Ltd. Long-acting preparation
JP3220373B2 (en) * 1995-11-28 2001-10-22 バイエル薬品株式会社 Long-acting nifedipine preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8153160B2 (en) 2005-07-06 2012-04-10 Bayer Pharma Aktiengesellschaft Pharmaceutical dosage forms comprising an active ingredient combination of nifedipine and/or nisoldipine and an angiotensin II antagonist
US9993432B2 (en) 2008-11-27 2018-06-12 Bayer Intellectual Property Gmbh Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin II antagonist and/or a diuretic

Also Published As

Publication number Publication date
WO2003080057A1 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
AU2003227409A1 (en) Slide core unit
AU2003239909A1 (en) Enhanced-service provision
AU2002335152A1 (en) Robot-phone
AU2003229066A1 (en) Interface architecture
AU2003252694A1 (en) External preparation
AU2003289290A1 (en) Remedy
AU2003902882A0 (en) Piperidyl derivatives
AU2002367810A1 (en) Bis-transition-metal-chelate-probes
AU2003227472A1 (en) Downsized core tablet containing nifedipine
AU2003264443A1 (en) Preparation for external use
AU2002318053A1 (en) Suplier
AU2002368348A1 (en) Electrosomatogram
AU2002341221A1 (en) Honey-brandy
AU2002348964A1 (en) Snowbike
AU2003212130A1 (en) Can
AU2003217027A1 (en) Object relationships
AU2002344387A1 (en) Multifunction-pillow
AU2003207055A1 (en) Novel drugs for external use
AU2002100791A4 (en) Maridevice core unit
AU2002354571A1 (en) Tablet cryotechnology
AU2002100026A4 (en) Disc400
AU2002100482A4 (en) Tail-gate-ezy
AU2002100508A4 (en) Photocard
AU2002100031A4 (en) earliPay
AU2002100498A4 (en) Linline

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase